ERYTHROMYCIN LACTOBIONATE

Glavne informacije

  • Zaščiteno ime:
  • ERYTHROMYCIN LACTOBIONATE 1g liofilizat
  • Farmacevtska oblika:
  • Liofilizat za raztopino za injiciranje
  • Pot uporabe:
  • Način uporabe nedoločen
  • Enote v paketu:
  • škatla z 1 vialo z 1 g liofilizata
  • Tip zastaranja:
  • / - Način/režim izdaje ni določen.
  • Uporabi za:
  • ljudje
  • Vrsta medicine:
  • Alopatska drog

Dokumentov

Lokalizacija

  • Na voljo v:
  • ERYTHROMYCIN LACTOBIONATE 1g liofilizat
    Slovenija
  • Jezik:
  • slovenščina

Terapevtski podatki

  • Terapevtska skupina:
  • eritromicin

Drugi podatki

Stanje

  • Source:
  • JAZMP - Javna agencija RS za zdravila in medicinske pripomočke - Slovenia Medicines Agency
  • Status dovoljenje:
  • Zdravilo z začasnim dovoljenjem za vnos/uvoz za posamično zdravl
  • Datum dovoljenje:
  • 28-12-2010
  • Zadnja posodobitev:
  • 19-01-2018

27-2-2019

The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017

The European Union summary report on antimicrobial resistance in zoonotic and indicator bacteria from humans, animals and food in 2017

Published on: Tue, 26 Feb 2019 The data on antimicrobial resistance in zoonotic and indicator bacteria in 2017, submitted by 28 EU Member States (MSs), were jointly analysed by EFSA and ECDC. Resistance in zoonotic Salmonella and Campylobacter from humans, animals and food, and resistance in indicator Escherichia coli as well as meticillin-resistant Staphylococcus aureus in animals and food were addressed, and temporal trends assessed. ‘Microbiological’ resistance was assessed using epidemiological cut-...

Europe - EFSA - European Food Safety Authority EFSA Journal

Ni novosti v zvezi s tem izdelkom